Cue Biopharma Inc

NASDAQ:CUE 1:00:00 PM EDT

0.70

0.00 (+0.46%)

3:58:57 PM EDT: $0.70 0.00 (0.69%)

Market Cap (Intraday)	52.38M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.4 Million
Adjusted EPS	-$0.14

See more estimates

10-Day MA	$0.70
50-Day MA	$0.70
200-Day MA	$1.02

See more pivots

Cue Biopharma Inc Stock, NASDAQ:CUE

40 Guest Street, Boston, Massachusetts 02135

United States of America

Phone: +1.617.949.2680

Number of Employees: 53

http://www.cuebiopharma.com

Description

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.